Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

22/09/2022 14:30

Jaguar Health to Present at Lytham Partners Fall 2022 Investor Conference on September 28th and at Ladenburg Thalmann 2022 Healthcare Conference on September 29th

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

30/08/2022 14:30

Jaguar Health Announces Submission of Investigational New Drug (IND) Application to FDA for Drug Candidate for the Symptomatic Relief of Diarrhea from Cholera

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

25/08/2022 14:30

Jaguar Health Secures Additional Capital Through Sale of Royalty Rights Related to Future Crofelemer and Lechlemer Revenue Stream

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

23/08/2022 14:30

Jaguar Health Announces that Orphan Drug Designation Application Submitted to the FDA for Crofelemer for a Severe Congenital Diarrheal Disorder (CDD) Has Been Accepted for Review

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

22/08/2022 14:00

Jaguar Health Provides Company Updates and Reports 2022 Second Quarter Financials

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

19/08/2022 14:30

Jaguar Health Receives Additional 180-day Grace Period to Regain Compliance with Nasdaq's Bid Price Rule

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

17/08/2022 14:30

Jaguar Health to Host Investor Webcast Monday, August 22nd at 8:30 AM Eastern Time Regarding Q2 2022 Financials & Corporate Updates

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

10/08/2022 14:30

Gallup Survey Estimates Nearly 30 Million U.S. Dog Owners Have Experienced Canine Cancer, with Many Saying it Negatively Impacted Their Own Quality of Life

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

09/08/2022 14:30

Jaguar Health Announces Issuance of U.S. Patent 11,389,424, a Methods and Compositions Patent for Treating Chemotherapy-Induced Diarrhea

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

05/08/2022 22:15

Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Voir tous les communiqués de Jaguar Health, Inc.

1
2
3
4
5
6
»